共 50 条
- [21] Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (02): : 137 - 147
- [23] Risks and clinical features of active tuberculosis developed in patients with inflammatory bowel disease receiving anti-tumour necrosis factor therapy JOURNAL OF CROHNS & COLITIS, 2016, 10 : S311 - S311
- [24] Anti-tumour necrosis factor therapy is associated with certain subtypes of chronic rhinosinusitis JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (06): : 560 - 564
- [30] European guidelines for the use of anti-tumour necrosis factor agents in inflammatory bowel disease International Journal of Colorectal Disease, 2001, 16 : 12 - 13